Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial - Locke, F L; Ghobadi, A; Jacobson, C A (Lancet Oncol, 2019)
. doi:10.1016/S1470-2045(18)30864-7